BiotechTube
Home/NGM Biopharmaceuticals/David J. Woodhouse, Ph.D.
DJ

David J. Woodhouse, Ph.D.

Chief Executive Officer

NGM Biopharmaceuticals

Therapeutic Areas

OncologyMetabolicOphthalmologyGastroenterology

NGM Biopharmaceuticals Pipeline

DrugIndicationPhase
NGM120Hyperemesis GravidarumPhase 2
NGM831 (MK-3655)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Phase 2b
NGM621Geographic Atrophy (GA)Phase 2
NGM438Genetic LipodystrophyPreclinical

Leadership Team at NGM Biopharmaceuticals

HD
Hsiao D. Lieu, M.D.
Chief Medical Officer
JV
John V. Gray, Ph.D.
President of Research & Chief Scientific Officer
R(
Robert (Bob) J. Thorne, Ph.D.
Co-Founder, Advisor & Board Member
View full NGM Biopharmaceuticals profile